From: Systematic review of health state utility values for economic evaluation of colorectal cancer
Valuation methods used | HSUVs reported | Reference |
---|---|---|
SG | Healthcare professionals; patients Disease recurrence 0.69; 0.72 Surgical resection 0.69; 0.83 Pain and complications 0.50; 0.78 | Miller [7] |
EQ-5D | PRT + TME 0.70-0.86 Recurrent 0.67 (local) 0.70 (distant) 0.48 (local/distant) TME 0.63-1.0 Recurrent 0.80 (local) 0.64 (distant) 0.45 (local/distant) | Van den Brink [27]a |
EQ-5D | Mean EQ-5D (SD) Baseline before TME 0.88 (0.15) 6Â weeks after TME 0.85(0.18) 12Â weeks after TME 0.87 (0.19) 26Â weeks after TME 0.88 (0.17) 52Â weeks after TME 0.86 (0.6) | Hompes [18] |